0001225208-17-016030.txt : 20171005 0001225208-17-016030.hdr.sgml : 20171005 20171005161607 ACCESSION NUMBER: 0001225208-17-016030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171003 FILED AS OF DATE: 20171005 DATE AS OF CHANGE: 20171005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bose Supratim CENTRAL INDEX KEY: 0001538431 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 171124733 MAIL ADDRESS: STREET 1: 11A COOLING CLOSE CITY: SINGAPORE STATE: U0 ZIP: 558176 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2017-10-03 0000885725 BOSTON SCIENTIFIC CORP BSX 0001538431 Bose Supratim 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP & President, Asia-Pacific Common Stock 2017-10-03 4 M 0 174672.0000 5.3600 A 494973.0000 D Common Stock 2017-10-03 4 M 0 22145.0000 6.2800 A 517118.0000 D Common Stock 2017-10-03 4 S 0 196817.0000 29.0789 D 320301.0000 D Common Stock 2017-10-04 4 M 0 88071.0000 7.3900 A 408372.0000 D Common Stock 2017-10-04 4 M 0 23907.0000 13.0800 A 432279.0000 D Common Stock 2017-10-04 4 M 0 15352.0000 6.2800 A 447631.0000 D Common Stock 2017-10-04 4 M 0 15086.0000 16.3100 A 462717.0000 D Common Stock 2017-10-04 4 M 0 7904.0000 17.2600 A 470621.0000 D Common Stock 2017-10-04 4 S 0 150320.0000 29.1800 D 320301.0000 D Stock Option (Right to Buy) 5.3600 2017-10-03 4 M 0 174672.0000 0.0000 D 2022-01-03 Common Stock 174672.0000 0.0000 D Stock Option (Right to Buy) 6.2800 2017-10-03 4 M 0 22145.0000 0.0000 D 2022-02-27 Common Stock 22145.0000 15352.0000 D Stock Option (Right to Buy) 17.2600 2017-10-04 4 M 0 7904.0000 0.0000 D 2026-02-22 Common Stock 7904.0000 23714.0000 D Stock Option (Right to Buy) 16.3100 2017-10-04 4 M 0 15086.0000 0.0000 D 2025-02-23 Common Stock 15086.0000 15086.0000 D Stock Option (Right to Buy) 13.0800 2017-10-04 4 M 0 23907.0000 0.0000 D 2024-02-24 Common Stock 23907.0000 7969.0000 D Stock Option (Right to Buy) 6.2800 2017-10-04 4 M 0 15352.0000 0.0000 D 2022-02-27 Common Stock 15352.0000 0.0000 D Stock Option (Right to Buy) 7.3900 2017-10-04 4 M 0 88071.0000 0.0000 D 2023-02-28 Common Stock 88071.0000 0.0000 D The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.4901, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.07 to $29.255, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on January 3, 2013, the first anniversary of the grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. /s/ Vance R. Brown, Attorney-in-fact 2017-10-05